Decheng Capital Management III (Cayman), LLC / NBP
Decheng Capital Management III (Cayman), LLC’s Novabridge Biosciences Position
Does Decheng Capital Management III (Cayman), LLC own Novabridge Biosciences (NBP)? Not currently — the last reported position was 4.17M shares worth $13M in Q3 2023; the fund’s latest 13F (Q4 2023) no longer reports it.
Position Value
$13M
Q3 2023
Shares
4.17M
% of Portfolio
+4.25%
Quarters Held
1
position exited
Position History NBP
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q3 2023 | 4.17M | $13M | +4.25% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Decheng Capital Management III (Cayman), LLC’s full portfolio or all institutional holders of NBP.